ADRB2 and Hypertension: A generalized impairment of βAR-mediated vasorelaxation has been indeed shown both in human hypertensive patients (Izzo et al., 2008) and in animal models of hypertension (Borkowski et al., 1992; Iaccarino et al., 2004; Santulli et al., 2009).